CMR Try CDLI online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by D'Alessandro, A.
Right arrow Articles by Rausch, R. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Alessandro, A.
Right arrow Articles by Rausch, R. L.
Clinical Microbiology Reviews, April 2008, p. 380-401, Vol. 21, No. 2
0893-8512/08/$08.00+0     doi:10.1128/CMR.00050-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

New Aspects of Neotropical Polycystic (Echinococcus vogeli) and Unicystic (Echinococcus oligarthrus) Echinococcosis

Antonio D'Alessandro1* and Robert L. Rausch2

Department of Tropical Medicine, School of Public Health and Tropical Medicine SL-29, Tulane University, 1440 Canal Street, Suite 2210, New Orleans, Louisiana 70112-2824,1 Department of Comparative Medicine, School of Medicine, University of Washington, Box 357190, Seattle, Washington 98195-71902

Summary: Of the four species of the genus Echinococcus (Cestoda) distinguished by biological and morphological characteristics, two species, E. vogeli and E. oligarthrus, occur widely in the Neotropics. Approximately 200 cases of polycystic echinococcosis (PE) have been recorded from 12 countries in South America. Following early proliferation of E. vogeli in the human host, typically in the liver, the metacestode usually spreads in the peritoneal and pleural cavities, and numerous organs may be invaded. The clinical characteristics of PE in 81 patients with sufficient information are reviewed. Type I disease consists of polycysts in the liver and abdominal cavity (37% of the patients had this characteristic); type II is similar to type I but also includes hepatic insufficiency (26%); type III consists of cysts in liver and chest (14%); type IV consists of cysts only in the mesenteries (16%); and type V consists of cysts calcified in liver and lung (4%). The percentage of patients with polycysts in the liver was 81%, and the percentage of patients with polycysts in the chest was 14%. PE is most ready diagnosed by geographic origin of the patient and by means of ultrasound or computerized tomography scanning showing cysts and calcifications. The highest mortality was for patients with type II disease, due to hepatic failure and its complications. There were five patients who died due to surgical accidents, whereas 35 cases had uncomplicated surgery. Twenty-three patients died of PE, making the total mortality 29% (23 of 78 cases). None of the 13 patients treated only with albendazole, the most efficacious treatment, was completely cured. PE represents a severe medical problem in South America. A reevaluation of the characteristics of the metacestode of E. oligarthrus indicated that it is unicystic. Only three human cases are known (two with infection in the orbit and one with infection in the heart). The metacestode of E. oligarthrus, in contrast with that of E. vogeli, consists of a spherical, fluid-filled vesicle that enlarges concentrically and is not known to undergo exogenous proliferation.


* Corresponding author. Present address: Arenales 2303, 3er piso, Buenos Aires 1124, Argentina. Phone: (54 11) 4824 1446. E-mail: adaless{at}tulane.edu


Clinical Microbiology Reviews, April 2008, p. 380-401, Vol. 21, No. 2
0893-8512/08/$08.00+0     doi:10.1128/CMR.00050-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.